Real-time Estimate Cboe BZX 10:59:31 2024-07-18 am EDT 5-day change 1st Jan Change
82.94 USD +2.07% Intraday chart for Medtronic plc +6.78% +1.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Baird Cuts Price Target on Medtronic to $82 From $87, Maintains Neutral Rating MT
Truist Trims Price Target on Medtronic to $85 From $88, Keeps Hold Rating MT
Mizuho Securities Cuts Price Target on Medtronic to $95 From $98 MT
Goldman Sachs Adjusts Price Target on Medtronic to $77 From $83 MT
Citigroup Adjusts Price Target on Medtronic to $85 From $90 MT
DexCom, Inc. : A Must-Have Tool for Diabetes Care Our Logo
NextEra Energy, Inc Announces the Appointment of Geoffrey S. Martha to Its Board of Directors CI
Stryker Corporation : Major Player in Medical Devices Our Logo
Spirit Aero chief in spotlight as Boeing searches for new CEO RE
Tech Up on Momentum Bets -- Tech Roundup DJ
HP Inc. recruits CFO from Medtronic CF
HP Poaches Medtronic Finance Chief Karen Parkhill DJ
HP Appoints Karen Parkhill Finance Chief MT
Medtronic says CFO Karen Parkhill to depart to join HP RE
Medtronic plc Announces CFO Changes CI
CVRx, Inc. Announces Appointment of Robert Allen John as Chief Revenue Officer, Effective June 27, 2024 CI
Sempra Appoints Jennifer M. Kirk to Board of Directors CI
Endologix LLC Appoints Graham Phillips as Chief Operating Officer CI
Edwards Lifesciences Corporation Announces Executive Changes CI
Medtronic Insider Sold Shares Worth $1,601,001, According to a Recent SEC Filing MT
Transcript : Medtronic plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM
Medtronic plc Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 CI
Medtronic Closes Offering of 3 Billion Euros of Notes MT
Daiwa Securities Adjusts Price Target on Medtronic to $92 From $100 MT
Medtronic Prices 3 Billion Euros Senior Notes Offering MT
Chart Medtronic plc
More charts
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.26 USD
Average target price
93.24 USD
Spread / Average Target
+14.74%
Consensus
  1. Stock Market
  2. Equities
  3. MDT Stock
  4. News Medtronic plc
  5. Medtronic Guides for Annual Growth in Fiscal 2025 as Fourth-Quarter Results Top Views